Prelude Therapeutics Incorporated (Nasdaq: PRLD), a precision oncology company, today is providing a number of strategic updates, including its recently executed option agreement with Incyte ...

Sample questions highlight topics like economic reforms, globalization, sustainable development, and regional economic ...

The following planning applications have been submitted to Horsham District Council between October 24 and 30.

Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination ...